Medchem Express Abt-737
ABT-737 |
|||
| A8193-10 | ApexBio | 10 mg | EUR 72 |
|
Description: Apoptosis|Bcl-2 Family#Apoptosis|Bcl-xL |
|||
Human IgG antibody Laboratories manufactures the medchem express abt-737 reagents distributed by Genprice. The Medchem Express Abt-737 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact MedChemExpress Inc.. Other Medchem products are available in stock. Specificity: Medchem Category: Express Group: Abt-737
ABT-737 |
||
| ApexBio | 500 mg | EUR 1040 |
|
Description: Apoptosis|Bcl-2 Family#Apoptosis|Bcl-xL |
||
ABT-737 |
||
| ApexBio | Evaluation Sample | EUR 24 |
|
Description: Apoptosis|Bcl-2 Family#Apoptosis|Bcl-xL |
||
ABT-737 |
||
| Biovision | each | EUR 810 |
ABT-737 |
||
| Biovision | each | EUR 248.4 |
ABT-737 |
||
| MedKoo Biosciences | 10.0mg | EUR 150 |
ABT-737 |
||
| Abbexa | 100 µl | EUR 156.25 |
ABT-737 |
||
| Abbexa | 1 ml | Ask for price |
ABT-737 |
||
| Abbexa | 200 µl | EUR 375 |
ABT 737 |
||
| Toronto Research Chemicals | 100mg | EUR 97 |
|
Description: 852808-04-9 |
||
ABT-737 |
||
| MyBiosource | 100mg | EUR 1065 |
ABT-737 |
||
| MyBiosource | 500mg | EUR 2775 |
ABT-737 |
||
| MedChemExpress | 10mM/1mL | EUR 357.15 |
|
Description: ABT-737, a BH3 mimetic, is a potent Bcl-2, Bcl-xL and Bcl-w inhibitor with EC50s of 30.3 nM, 78.7 nM, and 197.8 nM, respectively. ABT-737 induces the disruption of the BCL-2/BAX complex and BAK-dependent but BIM-independent activation of the intrinsic apoptotic pathway. ABT-737 induces autophagy and has the potential for acute myeloid leukemia (AML) research[1][2][3]. |
||
ABT-737 |
|||
| abx082597-100l | Abbexa | 100 µl | EUR 156.25 |
ABT-737 |
|||
| abx082597-1ml | Abbexa | 1 ml | Ask for price |
ABT-737 |
|||
| abx082597-200l | Abbexa | 200 µl | EUR 375 |
ABT-737 |
|||
| MBS130970-100mg | MyBiosource | 100mg | EUR 1065 |
ABT-737 |
|||
| MBS130970-500mg | MyBiosource | 500mg | EUR 2775 |
ABT-737 |
|||
| HY-50907 | MedChemExpress | 10mM/1mL | EUR 357.15 |
|
Description: ABT-737, a BH3 mimetic, is a potent Bcl-2, Bcl-xL and Bcl-w inhibitor with EC50s of 30.3 nM, 78.7 nM, and 197.8 nM, respectively. ABT-737 induces the disruption of the BCL-2/BAX complex and BAK-dependent but BIM-independent activation of the intrinsic apoptotic pathway. ABT-737 induces autophagy and has the potential for acute myeloid leukemia (AML) research[1][2][3]. |
|||
ABT-737 |
|||
| E1KS1002 | EnoGene | 5mg | EUR 362.4 |
ABT-737 |
|||
| GW8845 | Glentham Life Sciences | 1mg | EUR 283.49 |
ABT-737 |
|||
| GW8845-1 | Glentham Life Sciences | 1 | EUR 138.5 |
ABT-737 |
|||
| GW8845-10 | Glentham Life Sciences | 10 | EUR 270.5 |
ABT-737 |
|||
| GW8845-5 | Glentham Life Sciences | 5 | EUR 188 |
ABT-737 |
|||
| MBS575689-100mg | MyBiosource | 100mg | EUR 450 |
ABT-737 |
|||
| MBS575689-10mg | MyBiosource | 10mg | EUR 160 |
ABT-737 |
|||
| MBS575689-200mg | MyBiosource | 200mg | EUR 695 |
ABT-737 |
|||
| MBS575689-50mg | MyBiosource | 50mg | EUR 290 |
ABT-737 |
|||
| MBS575689-5mg | MyBiosource | 5mg | EUR 155 |
ABT-737 |
|||
| MBS385210-100mg | MyBiosource | 100mg | EUR 615 |
ABT-737 |
|||
| MBS385210-10mg | MyBiosource | 10mg | EUR 180 |
ABT-737 |
|||
| MBS385210-1mLinDMSO | MyBiosource | 1mL(inDMSO) | EUR 170 |
ABT-737 |
|||
| MBS385210-50mg | MyBiosource | 50mg | EUR 405 |
ABT-737 |
|||
| MBS385210-5mg | MyBiosource | 5mg | EUR 140 |
ABT-737 |
|||
| MBS3606192-100mg | MyBiosource | 100mg | EUR 495 |
ABT-737 |
|||
| MBS3606192-10mg | MyBiosource | 10mg | EUR 235 |
ABT-737 |
|||
| MBS3606192-25mg | MyBiosource | 25mg | EUR 305 |
ABT-737 |
|||
| MBS3606192-50mg | MyBiosource | 50mg | EUR 390 |
ABT-737 |
|||
| MBS3606192-5mg | MyBiosource | 5mg | EUR 210 |
ABT-737 |
|||
| MBS8506577-5mg | MyBiosource | 5mg | EUR 440 |
ABT-737 |
|||
| MBS8506577-5x5mg | MyBiosource | 5x5mg | EUR 1835 |